\-\ Texto\\:\\ \ \(0\)\
\-\ asymptomatic\ \(399\)\
\-\ nil\ \(285\)\
\-\ transverse\\ image\\ of\\ left\\ kidney\\ showing\\ absence\\ of\\ hilar\\ fat\\ in\\ midpole\\.\ \(0\)\
\-\ coronal\\ view\\ confirmed\\ a\\ complete\\ band\\ of\\ renal\\ cortex\\-diagnostic\\ for\\ duplex\\ kidney\\.\ \(0\)\
\-\ faceless\\ kidney\\ sign\ \(4\)\
\-\ renal\\ duplication\ \(0\)\
\-\ hypertrophied\\ cloumn\\ of\\ bertin\\.\ \(0\)\
\-\ lobar\\ dysmorphism\ \(2\)\
\-\ nodular\\ compensatory\\ hypertrophy\ \(2\)\
\-\ segmental\\ infarction\ \(3\)\
\-\ pyelonephritis\ \(60\)\
\-\ infiltrative\\ diseases\ \(1\)\
\-\ tumors\\ like\\ transitional\\ cell\\ carcinoma\\ and\\ other\\ primary\\ tumors\ \(1\)\
\-\ routine\\ health\\ check\\ up\\ ultrasound\\.\ \(0\)\
\-\ ultrasound\\ equialent\\ of\\ \\'faceless\\ kidney\\ sign\\'\\.\ \(0\)\
\-\ hypertrophied\\ column\\ of\\ bertin\\ \\-these\\ are\\ group\\ of\\ renal\\ pseudotumors\\ characterised\\ by\\ focal\\ displacement\\ of\\ the\\ collecting\\ system\\ within\\ kidney\\ of\\ normal\\ contour\\.\ \(0\)\
\-\ they\\ usually\\ occur\\ in\\ the\\ presence\\ of\\ partial\\ or\\ complete\\ duplication\\ of\\ pelvicalyceal\\ system\\.\ \(0\)\
\-\ mass\\ effect\\ seen\\ most\\ frequently\\ \\,although\\ not\\ invariably\\ in\\ the\\ area\\ between\\ the\\ upper\\ and\\ inter\\ polar\\ areas\\ of\\ the\\ kidney\\.\ \(0\)\
\-\ in\\ many\\ instances\\ what\\ causes\\ this\\ mass\\ effect\\ is\\ normal\\ septal\\ cortex\\ tissue\\ that\\ has\\ persisted\\ during\\ lobar\\ fusion\\ and\\ in\\ the\\ process\\ has\\ become\\ relatively\\ prominent\\.\ \(0\)\
\-\ lobar\\ dysmorphism\\ \\-\\ this\\ is\\ another\\ form\\ of\\ pseudotumor\\ that\\ is\\ very\\ similar\\ to\\ large\\ cloison\\ \\.here\\ a\\ complete\\ though\\ diminutive\\ lobe\\ is\\ situated\\ atypically\\ deep\\ within\\ the\\ renal\\ substance\\.\ \(0\)\
\-\ as\\ with\\ septum\\ of\\ bertin\\ this\\ is\\ associated\\ with\\ duplication\\ of\\ the\\ collecting\\ system\\ and\\ will\\ focally\\ displace\\ the\\ pelvis\\ or\\ calyces\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ nodular\\ compensatory\\ hypertrophy\\ \\-in\\ the\\ presence\\ of\\ focal\\ renal\\ scarring\\ \\,\\ areas\\ of\\ unaffected\\ normal\\ renal\\ tissue\\ will\\ undergo\\ compensatory\\ hypertrophy\\.focal\\ enlargement\\ of\\ deeply\\ situated\\ septal\\ cortex\\ has\\ ben\\ described\\ in\\ analgesic\\ nephropathy\\.\ \(0\)\
\-\ lobar\\ infarction\\ \\-\\ edematous\\ phase\\ of\\ acute\\ renal\\ infarction\\ can\\ simulate\\ faceless\\ kidney\\ appearance\\.also\\ pyelonepritis\\ ca\\ n\\ cause\\ similar\\ appearance\\.doppler\\ sonography\\ will\\ show\\ these\\ aras\\ as\\ hypovascular\\.\ \(0\)\
\-\ tumors\\ \\-\\ renal\\ cell\\ carcinoma\\ \\,\\ and\\ aother\\ solid\\ tumors\\ of\\ kidney\\ including\\ metstasis\\ can\\ show\\ smilar\\ imaging\\ findings\\.\ \(0\)\
\-\ infiltrative\\ diseases\\ \\-neoplastic\\ cell\\ infiltration\\ generally\\ cause\\ bilateral\\ diffuse\\ renal\\ enlargement\\.however\\ rarely\\ leukemia\\ causes\\ unifocal\\ renal\\ mass\\ due\\ to\\ a\\ chloroma\\ \\,myeloblastoma\\,\\ myeloblastic\\ sarcoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.3041740119488073\ \(0\)\
\-\ kidney\\:\\ 0\\.2745253594544711\ \(0\)\
\-\ faceless\\:\\ 0\\.21653734751687786\ \(0\)\
\-\ lobar\\:\\ 0\\.20152885962220038\ \(0\)\
\-\ bertin\\:\\ 0\\.19873148443972044\ \(0\)\
\-\ of\\:\\ 0\\.1911765110431205\ \(0\)\
\-\ compensatory\\:\\ 0\\.180925621362563\ \(0\)\
\-\ duplication\\:\\ 0\\.1482894327348564\ \(0\)\
\-\ tumors\\:\\ 0\\.14369306324802422\ \(0\)\
\-\ dysmorphism\\:\\ 0\\.14053675995908224\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.13802433625435082\ \(0\)\
\-\ situated\\:\\ 0\\.13047054875376854\ \(0\)\
\-\ cortex\\:\\ 0\\.11932745563631805\ \(0\)\
\-\ infarction\\:\\ 0\\.11503609841606753\ \(0\)\
\-\ system\\:\\ 0\\.11179181084814892\ \(0\)\
\-\ hypertrophied\\:\\ 0\\.10985176772746394\ \(0\)\
\-\ complete\\:\\ 0\\.10271661874115123\ \(0\)\
\-\ infiltrative\\:\\ 0\\.10010567089359398\ \(0\)\
\-\ the\\:\\ 0\\.0974642410967851\ \(0\)\
\-\ septal\\:\\ 0\\.09509834566809931\ \(0\)\
\-\ will\\:\\ 0\\.09431458888904241\ \(0\)\
\-\ collecting\\:\\ 0\\.09161793598016543\ \(0\)\
\-\ diseases\\:\\ 0\\.08975461952135713\ \(0\)\
\-\ focal\\:\\ 0\\.08765130383140791\ \(0\)\
\-\ in\\:\\ 0\\.08505802505790834\ \(0\)\
\-\ cell\\:\\ 0\\.08382543113068618\ \(0\)\
\-\ cloumn\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ equialent\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ characterised\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ cloison\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ ben\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ aras\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ aother\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ metstasis\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ smilar\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ myeloblastoma\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ myeloblastic\\:\\ 0\\.0781144035313451\ \(0\)\
\-\ nodular\\:\\ 0\\.07779599448123863\ \(0\)\
\-\ enlargement\\:\\ 0\\.0748946035490241\ \(0\)\
\-\ nil\\:\\ 0\\.07464248280030761\ \(0\)\
\-\ pseudotumors\\:\\ 0\\.07464248280030761\ \(0\)\
\-\ pelvicalyceal\\:\\ 0\\.07464248280030761\ \(0\)\
\-\ pyelonepritis\\:\\ 0\\.07464248280030761\ \(0\)\
\-\ unifocal\\:\\ 0\\.07464248280030761\ \(0\)\
\-\ similar\\:\\ 0\\.07445546102030674\ \(0\)\
\-\ causes\\:\\ 0\\.07381716526719019\ \(0\)\
\-\ midpole\\:\\ 0\\.07217911583895929\ \(0\)\
\-\ atypically\\:\\ 0\\.07217911583895929\ \(0\)\
\-\ deeply\\:\\ 0\\.07217911583895929\ \(0\)\
\-\ analgesic\\:\\ 0\\.07026837997954112\ \(0\)\
\-\ presence\\:\\ 0\\.07019173713099769\ \(0\)\
\-\ diminutive\\:\\ 0\\.06870719510792178\ \(0\)\
\-\ chloroma\\:\\ 0\\.06870719510792178\ \(0\)\
\-\ effect\\:\\ 0\\.06852879093300489\ \(0\)\
\-\ sign\\:\\ 0\\.06763247835369418\ \(0\)\
\-\ invariably\\:\\ 0\\.0673872321066837\ \(0\)\
\-\ has\\:\\ 0\\.06693344525169784\ \(0\)\
\-\ is\\:\\ 0\\.06688320204431718\ \(0\)\
\-\ cause\\:\\ 0\\.06655149059789542\ \(0\)\
\-\ areas\\:\\ 0\\.06632525718588705\ \(0\)\
\-\ polar\\:\\ 0\\.06624382814657348\ \(0\)\
\-\ hypovascular\\:\\ 0\\.06624382814657348\ \(0\)\
\-\ simulate\\:\\ 0\\.06351696931498263\ \(0\)\
\-\ inter\\:\\ 0\\.06277190741553597\ \(0\)\
\-\ displace\\:\\ 0\\.06277190741553597\ \(0\)\
\-\ show\\:\\ 0\\.062016348106121603\ \(0\)\
\-\ instances\\:\\ 0\\.06145194441429787\ \(0\)\
\-\ unaffected\\:\\ 0\\.06086117155611779\ \(0\)\
\-\ nephropathy\\:\\ 0\\.06086117155611779\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0602574796238245\ \(0\)\
\-\ normal\\:\\ 0\\.05982972894312816\ \(0\)\
\-\ substance\\:\\ 0\\.05929998668449846\ \(0\)\
\-\ carcinoma\\:\\ 0\\.05843420255427194\ \(0\)\
\-\ persisted\\:\\ 0\\.057201049620201026\ \(0\)\
\-\ focally\\:\\ 0\\.057201049620201026\ \(0\)\
\-\ duplex\\:\\ 0\\.05683661972315015\ \(0\)\
\-\ calyces\\:\\ 0\\.05683661972315015\ \(0\)\
\-\ mass\\:\\ 0\\.055972898853058874\ \(0\)\
\-\ check\\:\\ 0\\.05521617641350604\ \(0\)\
\-\ these\\:\\ 0\\.055165961829526204\ \(0\)\
\-\ transitional\\:\\ 0\\.05267930848480913\ \(0\)\
\-\ edematous\\:\\ 0\\.05246251690238366\ \(0\)\
\-\ column\\:\\ 0\\.05184324880952062\ \(0\)\
\-\ sonography\\:\\ 0\\.05184324880952062\ \(0\)\
\-\ can\\:\\ 0\\.05126502073263523\ \(0\)\
\-\ tissue\\:\\ 0\\.051246375526394904\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.05072477298963644\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.05072477298963644\ \(0\)\
\-\ and\\:\\ 0\\.05046650350424016\ \(0\)\
\-\ scarring\\:\\ 0\\.050382214905550095\ \(0\)\
\-\ this\\:\\ 0\\.050352461271407495\ \(0\)\
\-\ band\\:\\ 0\\.0494298109116188\ \(0\)\
\-\ health\\:\\ 0\\.048305205664042644\ \(0\)\
\-\ infiltration\\:\\ 0\\.04817447319917348\ \(0\)\
\-\ what\\:\\ 0\\.04696644395027049\ \(0\)\
\-\ group\\:\\ 0\\.04642085753003762\ \(0\)\
\-\ segmental\\:\\ 0\\.04631579105701843\ \(0\)\
\-\ septum\\:\\ 0\\.04590796111713479\ \(0\)\
\-\ undergo\\:\\ 0\\.045614350291744675\ \(0\)\
\-\ within\\:\\ 0\\.04499335579305489\ \(0\)\
\-\ hilar\\:\\ 0\\.04478948529725062\ \(0\)\
\-\ leukemia\\:\\ 0\\.04461649335057966\ \(0\)\
\-\ contour\\:\\ 0\\.04395749056868931\ \(0\)\
\-\ rarely\\:\\ 0\\.043569966968239386\ \(0\)\
\-\ become\\:\\ 0\\.0433456010287344\ \(0\)\
\-\ form\\:\\ 0\\.04270575749116149\ \(0\)\
\-\ though\\:\\ 0\\.042436040386097294\ \(0\)\
\-\ that\\:\\ 0\\.04239413021432469\ \(0\)\
\-\ showing\\:\\ 0\\.04217456021799487\ \(0\)\
\-\ phase\\:\\ 0\\.041796727891975194\ \(0\)\
\-\ ca\\:\\ 0\\.041674399952681844\ \(0\)\
\-\ generally\\:\\ 0\\.04137601400899706\ \(0\)\
\-\ fusion\\:\\ 0\\.04103115625788466\ \(0\)\
\-\ sarcoma\\:\\ 0\\.04097500648212676\ \(0\)\
\-\ frequently\\:\\ 0\\.040225282012393344\ \(0\)\
\-\ another\\:\\ 0\\.03997267342474897\ \(0\)\
\-\ displacement\\:\\ 0\\.03982460961830406\ \(0\)\
\-\ relatively\\:\\ 0\\.03977581854543935\ \(0\)\
\-\ described\\:\\ 0\\.039631091548851576\ \(0\)\
\-\ as\\:\\ 0\\.03924584901219699\ \(0\)\
\-\ absence\\:\\ 0\\.038942022068292746\ \(0\)\
\-\ coronal\\:\\ 0\\.03889799724061931\ \(0\)\
\-\ many\\:\\ 0\\.038511639520778455\ \(0\)\
\-\ prominent\\:\\ 0\\.038469767505214435\ \(0\)\
\-\ deep\\:\\ 0\\.03802220287630349\ \(0\)\
\-\ routine\\:\\ 0\\.03782624901347494\ \(0\)\
\-\ transverse\\:\\ 0\\.037634679275853566\ \(0\)\
\-\ partial\\:\\ 0\\.037634679275853566\ \(0\)\
\-\ solid\\:\\ 0\\.03744730177451205\ \(0\)\
\-\ process\\:\\ 0\\.03663454932398103\ \(0\)\
\-\ like\\:\\ 0\\.03630389781440184\ \(0\)\
\-\ confirmed\\:\\ 0\\.03601684936776189\ \(0\)\
\-\ occur\\:\\ 0\\.035923265812006056\ \(0\)\
\-\ view\\:\\ 0\\.0357695308007044\ \(0\)\
\-\ very\\:\\ 0\\.035039718789740944\ \(0\)\
\-\ including\\:\\ 0\\.03495617851618576\ \(0\)\
\-\ they\\:\\ 0\\.03490093438830653\ \(0\)\
\-\ pelvis\\:\\ 0\\.034162758544816055\ \(0\)\
\-\ or\\:\\ 0\\.03398487903548665\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.033253002098007564\ \(0\)\
\-\ although\\:\\ 0\\.033253002098007564\ \(0\)\
\-\ between\\:\\ 0\\.03173736419611883\ \(0\)\
\-\ area\\:\\ 0\\.03164274654699539\ \(0\)\
\-\ image\\:\\ 0\\.031238418599950333\ \(0\)\
\-\ during\\:\\ 0\\.03093855732715783\ \(0\)\
\-\ usually\\:\\ 0\\.030749979312662455\ \(0\)\
\-\ diffuse\\:\\ 0\\.03063210199225856\ \(0\)\
\-\ fat\\:\\ 0\\.03038484294227096\ \(0\)\
\-\ primary\\:\\ 0\\.030034642050474236\ \(0\)\
\-\ lobe\\:\\ 0\\.028227470852430235\ \(0\)\
\-\ due\\:\\ 0\\.028077242260202064\ \(0\)\
\-\ acute\\:\\ 0\\.026423485566758487\ \(0\)\
\-\ bilateral\\:\\ 0\\.026251312087887824\ \(0\)\
\-\ upper\\:\\ 0\\.026102217024828397\ \(0\)\
\-\ associated\\:\\ 0\\.025745180546098458\ \(0\)\
\-\ imaging\\:\\ 0\\.025669902609667603\ \(0\)\
\-\ most\\:\\ 0\\.025420617216652737\ \(0\)\
\-\ other\\:\\ 0\\.025366192392838084\ \(0\)\
\-\ large\\:\\ 0\\.024473962326134444\ \(0\)\
\-\ to\\:\\ 0\\.024422500369928147\ \(0\)\
\-\ up\\:\\ 0\\.02416197116450818\ \(0\)\
\-\ findings\\:\\ 0\\.02410715646352119\ \(0\)\
\-\ seen\\:\\ 0\\.0229960115442434\ \(0\)\
\-\ by\\:\\ 0\\.020742583175663014\ \(0\)\
\-\ not\\:\\ 0\\.019282995901778486\ \(0\)\
\-\ with\\:\\ 0\\.01912907389629139\ \(0\)\
\-\ are\\:\\ 0\\.018534601953472063\ \(0\)\
\-\ left\\:\\ 0\\.01666222598050521\ \(0\)\
\-\ for\\:\\ 0\\.01480466117772802\ \(0\)\
